EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Evaluation of sample pooling using Xpert Carba-R and Xpert vanA / vanB PCR for screening of carbapenemase-producing Enterobacterales and vancomycin-resistant Enterococcus colonization

Danielle Keidar-Friedman iD, Larissa Gil, Anka Tsur, Tal Brosh-Nissimov, Yehuda Carmeli, Boaz David Rosenfeld, Nadav Sorek

Microbiology Spectrum · 07.10.2025 · 13 (10)

DOI: 10.1128/spectrum.01080-25 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Microbiology Spectrum, erschienen am 07.10.2025. Verfasst von Danielle Keidar-Friedman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Emerging Infectious Diseases Research Laboratory, Samson Assuta Ashdod University Hospital, Ashdod, Israel. Hauptthemen laut MEDLINE: Vancomycin-Resistant Enterococci, Bacterial Proteins, Polymerase Chain Reaction, Enterobacteriaceae Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Screening for carbapenemase-producing Enterobacterales (CPE) and vancomycin-resistant Enterococcus (VRE) colonization among hospitalized patients is a standard infection control procedure that also guides appropriate antibiotic treatment in healthcare settings. Extensive CPE screening in low-prevalence regions imposes a considerable laboratory workload and substantial costs that can be mitigated through the utilization of pool testing. In this study, we evaluated PCR pooling for the detection of CPE and VRE colonization from rectal swabs collected in our hospital, using the Xpert Carba-R and Xpert vanA/vanB assays. CPE pooling demonstrated excellent performance, with 94.44% sensitivity (74.2–99.0 CI 95%), 100% specificity (99.1–100), 100% positive predictive value (81.6–100), and 99.78% (98.7–100) negative predictive value (NPV). In contrast, VRE detection showed lower performance, with 75.86% (63.5–85.0 CI 95%) specificity and 100% (92.0–100) NPV, primarily due to false-positive results for the vanB gene. Overall, the pooling technique showed great potential for CPE screening in low-prevalence settings. Further studies are needed to evaluate VRE pooling and clarify the clinical utility of PCR results for vanB , which currently requires culture confirmation. IMPORTANCE Carbapenemase-producing Enterobacterales (CPE) and vancomycin-resistant enterococci (VRE) pose a major threat to healthcare systems due to their role in hospital-acquired infections and limited treatment options. Routine screening for CPE/VRE colonization is essential for preventing transmission, yet conventional culture-based methods are labor-intensive and time-consuming. This study demonstrates that PCR pooling is a highly effective and resource-efficient approach for CPE screening in low-prevalence settings, maintaining high sensitivity and specificity while reducing laboratory workload. The performance of VRE pooling, particularly for vanB detection, requires further evaluation. These findings support the adoption of pooling strategies for CPE surveillance and highlight the need for improved molecular diagnostics for VRE, offering a promising solution to address growing challenges in clinical microbiology diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vancomycin-Resistant EnterococciBacterial ProteinsPolymerase Chain ReactionEnterobacteriaceae InfectionsEnterobacteriaceaeGram-Positive Bacterial InfectionsHumansSensitivity and Specificitybeta-LactamasesCarbon-Oxygen LigasesRectumMass ScreeningMolecular Diagnostic Techniques

Stichwörter der Autor:innen

antimicrobial resistancecarbapenemase-producing Enterobacteralesclinical microbiology diagnosticshealthcare-associated infectionsvancomycin-resistant enterococci

Substanzen

Bacterial Proteinsbeta-LactamasescarbapenemaseVanA ligase, BacteriaCarbon-Oxygen LigasesVanB protein, Enterococcus

Autor:innen und Institutionen

  • Emerging Infectious Diseases Research Laboratory, Samson Assuta Ashdod University Hospital, Ashdod, Israel.
  • Clinical Microbiology Laboratory, Samson Assuta Ashdod University Hospital, Ashdod, Israel.
  • Infectious Diseases Unit, Samson Assuta Ashdod University Hospital, Ashdod, Israel.
  • Faculty of Health Sciences, Ben Gurion University in the Negev, Beer Sheba, Israel.
  • National Institute for Antibiotic Resistance and Infection Control, Tel Aviv, Israel.
  • Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.

ORCID-Profile: Danielle Keidar-Friedman

Zitieren

APA

Keidar-Friedman, D., Gil, L., Tsur, A., Brosh-Nissimov, T., Carmeli, Y., Rosenfeld, B. D., & Sorek, N. (2025). Evaluation of sample pooling using Xpert Carba-R and Xpert vanA / vanB PCR for screening of carbapenemase-producing Enterobacterales and vancomycin-resistant Enterococcus colonization. Microbiology Spectrum, 13(10). https://doi.org/10.1128/spectrum.01080-25

Vancouver

Keidar-Friedman D, Gil L, Tsur A, Brosh-Nissimov T, Carmeli Y, Rosenfeld BD, et al. Evaluation of sample pooling using Xpert Carba-R and Xpert vanA / vanB PCR for screening of carbapenemase-producing Enterobacterales and vancomycin-resistant Enterococcus colonization. Microbiology Spectrum. 2025;13(10). doi:10.1128/spectrum.01080-25

BibTeX
@article{KeidarFriedman2025,
  author = {Keidar-Friedman, Danielle and Gil, Larissa and Tsur, Anka and Brosh-Nissimov, Tal and Carmeli, Yehuda and Rosenfeld, Boaz David and Sorek, Nadav},
  title = {Evaluation of sample pooling using Xpert Carba-R and Xpert vanA / vanB PCR for screening of carbapenemase-producing Enterobacterales and vancomycin-resistant Enterococcus colonization},
  journal = {Microbiology Spectrum},
  year = {2025},
  volume = {13},
  number = {10},
  doi = {10.1128/spectrum.01080-25}
}
Kostenlos starten →